{
  "id": 3517,
  "text": "Eur J Cancer Suppl 2-3, 7 (2009).1491.Duenas-Gonzalez, A., et al.A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Eur J Cancer Suppl 2-3, 7 (2009).1491.Duenas-Gonzalez, A., et al.A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "该研究探讨了吉西他滨加顺铂与放疗的联合疗法，随后进行吉西他滨加顺铂的辅助治疗，与顺铂联合放疗的疗法在IIB至IVA期宫颈癌患者中的效果比较。",
  "query": "**该研究探讨了哪种治疗组合更适用于IIB至IVA期宫颈癌患者？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **该研究探讨了哪种治疗组合更适用于IIB至IVA期宫颈癌患者？**\n\n<reference text>: Eur J Cancer Suppl 2-3, 7 (2009).1491.Duenas-Gonzalez, A., et al.A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "该研究探讨了吉西他滨加顺铂与放疗的联合疗法，随后进行吉西他滨加顺铂的辅助治疗，与顺铂联合放疗的疗法在IIB至IVA期宫颈癌患者中的效果比较。"
}